Neuland Laboratories Ltd
NSE:NEULANDLAB
Neuland Laboratories Ltd
NSE:NEULANDLAB
Price:
13 508
INR
-2.75%
Market Closed
Market Cap:
₹173.3B
Relative Value
The Relative Value of one
NEULANDLAB
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 13 508 INR,
Neuland Laboratories Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NEULANDLAB Relative Value
HIDDEN
Multiples Across Competitors
NEULANDLAB Competitors Multiples
Neuland Laboratories Ltd Competitors
Neuland Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Neuland Laboratories Ltd
NSE:NEULANDLAB
|
173.6B INR | 11.3 | 72.2 | 52.9 | 68.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
991B USD | 15 | 47.3 | 31.9 | 33.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.2B USD | 6.1 | 21.4 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
279.8B CHF | 4.5 | 29.7 | 12.6 | 14.6 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.7B CHF | 5.3 | 21.3 | 13.2 | 16.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
220.7B GBP | 5.2 | 32.4 | 15.4 | 22.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
293B USD | 4.5 | 15.9 | 10 | 11.7 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.6 | 9.9 | 11.6 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
154.8B USD | 2.5 | 20.1 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
124.6B USD | 2.6 | 17.5 | 6.8 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
